Veilpoint Medical / Connected injection care

Injection support designed around the person using it.

AutoIM and AutoSQ are reusable injection aid concepts designed to keep the syringe out of sight and guide servo-controlled insertion, delivery, and retraction through a clear touchscreen, haptic, and audio sequence.

Servo-guided automation

Controlled insertion, delivery, and retraction instead of one fixed spring-fired event.

IM sensing concept

A safety-focused sensing and pause/retract workflow is part of AutoIM development.

Haptic and audio feedback

Progress cues are designed to reduce the need to watch each mechanical step.

Eyes-away initiation

The syringe remains obscured while the interface guides positioning and completion.

Familiar syringe strategy

Compatibility work centers on standard prescription syringe formats rather than proprietary cartridges.

Direct access planned

Consumer and clinic purchasing pathways are part of launch planning after required clearance.

Products are currently in development. Features and intended uses remain subject to validation.

Injection platformConcept in development
Veilpoint AutoIM touchscreen injection aid concept
Injection platformConcept in development
Veilpoint AutoSQ compact touchscreen injection aid concept

Intramuscular injection support

AutoIM

A reusable intramuscular injection aid concept designed to obscure the syringe and guide positioning, insertion, delivery, and retraction through a touchscreen, haptic, and audio sequence.
  • Touchscreen guided
  • Sensing workflow concept

Subcutaneous injection support

AutoSQ

A more compact subcutaneous injection aid concept built around the same obscured-syringe, eyes-away experience for therapies delivered beneath the skin.
  • Compact design
  • Guided no-look initiation

Connected software

Support for patients. Context for care teams.

Track+ and CliniTrack are being shaped as two sides of the same therapy story: one helps patients manage what happens at home, while the other helps care teams understand what may need attention.

Track+Patient view / 01
9:41

Next dose

Thursday, 7:30 PM
Therapy planOn track
Injection history12 entries
Refill estimate18 days
TodayLogHistory
Patient experience

Track+

Give patients a calm place to log doses, manage site rotation, anticipate refills, and preserve important context between appointments.

Explore Track+ ->
CliniTrackCare-team view / 01
Patient overviewActive cohort
94%Reported doses
08Follow-ups
21Active patients
Care-team experience

CliniTrack

Bring therapy activity, patient-reported context, and potential follow-up needs into a focused clinical workflow.

Explore CliniTrack ->

Why Veilpoint

Designed around the reality of care at home.

Veilpoint began with a founder facing the same problem the platform is being built to address: how to manage a recurring injection responsibly when fear, technique, and limited support all converge at home.

01

Born from direct experience

The company was founded by a Marine Corps veteran who brought advanced-manufacturing problem solving to his own challenge with needle anxiety and recurring therapy.

02

Clinically responsible

Product concepts are framed with measured claims, human-factors planning, risk management, and the operational realities of care teams in mind.

03

Connected by design

Device support, patient activity, and authorized clinical context are treated as one care journey rather than disconnected products.

04

Built to earn trust

Explicit consent, clear interfaces, transparent development status, and respect for sensitive health information guide the platform.

One care philosophy

From the injection moment to the next conversation.

Platform logic

Support the person. Inform the team. Improve the moment.

AutoIM and AutoSQ focus on the physical and emotional experience of injection. Track+ preserves the patient's therapy story. CliniTrack helps care teams use that context. Each product stands on its own while contributing to a clearer care journey.

  • Track routines and preserve patient-reported context
  • Surface useful signals for appropriate follow-up
  • Reduce unnecessary visual and procedural stress
  • Build toward pilots, partnerships, and validation

Development approach

Measured progress, with the end user in view.

01Human-centered discovery
02Iterative product validation
03Responsible market readiness

Start a conversation

Interested in the next phase of Veilpoint?

We welcome conversations with clinicians, research teams, patient advocates, strategic partners, and early supporters.

Contact Veilpoint->